Click here to see this online
 
 
 

March 7, 2019

 
 
NEWS
 
 
 

Cancer Center Member Named Co-Chair of Beckman's Integrative Imaging Research Theme
Wawrzyniec Dobrucki will now serve as the co-chair of the Integrative Imaging Research Theme at the Beckman Institute. Dobrucki's research focuses on integrated imaging approaches to noninvasively monitor and track physiologic processes within the tumor microenvironment. Find out more here.

 

 
 
 
 
 

Cancer Center Member Among First to Count Growth Factors in Single Cells
Andrew Smith worked with other researchers to develop a new technology platform that digitally counts growth factors in an individual cell. This technology may lead to better understandings of cellular response to drugs and why cells become resistant, particularly in cancer treatments. A fellow CCIL member, Pablo Perez-Pinera, was given a grant to further research this technology. Read more here. 

 
UPCOMING EVENTS

March Faculty Seminar Series
Join us for March Faculty Seminar Series on March 14 from 3:00 to 4:00 p.m. at Beckman Institute (Room 4269) featuring Cecilia Leal, Assistant Professor of Materials Science and Engineering, and Raven Huang, Professor of Biochemistry. Learn more.

 
 
 
 

C*STAR Spring Reception and Poster Session
Save April 24, 2019, for the upcoming C*STAR Spring Reception and Poster Session at the Beckman Institute. More details to come.

 
 
 
 

Register for the TiMe Day Symposium
The third annual TiMe Day Symposium on April 26, 2019, will highlight research from the program, include keynote and plenary talks, and culminate with a poster session in which all graduate and undergraduate students are encouraged to present their work. Illinois faculty, staff, and students are welcome to attend this event, and graduate students and undergraduates conducting tissue microenvironment-related research are invited to submit abstracts and present posters. Reserve your spot here

 
 
 
 

Register Now for Cancer Research Advocacy Day
Registration is now open for Cancer Research Advocacy Day. The event is a way to promote interactions between cancer survivors, researchers, and clinicians and honor those who have been impacted by the disease. View the agenda, check out the scheduled speakers, and reserve your spot here.

 
 
 
 

Molecular and Integrative Physiology Seminar
Tumor Microenvironment and Dormancy
March 28, 2019
11:00 a.m.
Charles Miller Auditorium, B102, CLSL

Cyrus Ghajar, PhD
Fred Hutchinson Cancer Research Center

School of Chemical Sciences Seminar
Molecular Mechanism of Integral Membrane Enzymes that Catalyze Protein Lipidation
March 8th, 2019
12:00 p.m.
Charles Miller Auditorium, B102, CLSL

Dr. Anirban Banerjee
National Institute of Health

 
CAMPUS FUNDING OPPORTUNITIES

Public Voices Fellowship
Executive Vice President/Vice President for Academic Affairs
Deadline: April 26, 2019 

 
EXTERNAL FUNDING OPPORTUNITIES

Damon Runyon Cancer Research Foundation Fellowship Program
Damon Runyon Cancer Research Foundation
Deadline: March 15, 2019

ACS Research Grants
The American Cancer Society
Deadline: April 1, 2019

**New** Tina's Wish Rising Star Grants 
Tina Brozman Foundation
Deadline: April 29, 2019

1. Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
2. Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
National Institutes of Health
Deadline: September 27, 2019

1. Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
2. Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
National Institutes of Health
Deadline: September 27, 2019

1. Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
2. Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
3. Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health
Deadline: September 27, 2019
 

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Department of Health and Human Services
August 3, 2020

FY19 Breast Cancer Research Program
DOD
Deadlines Vary

 
 

If you received an award, published a paper, or have news to share, we want to hear from you.
Send your news items to cancercenter@illinois.edu

Visit the Cancer Center Events Calendar
for upcoming cancer-related activities and events.

Follow us on Twitter at @CancerCenterIL.


cancer.illinois.edu | cancercenter@illinois.edu | @CancerCenterIL